The current landscape of clinical studies is quickly evolving, spurred by novel approaches to therapeutic development. From individualized medicine, leveraging molecular data to inform treatment approaches, to the investigation of sophisticated immunotherapies, practitioners are experiencing a fundamental shift in how we tackle disease. A critical